Senseonics HoldingsSENS -5.33%60 Return-on-Tangible-Equity is -273.72% as of Mar. 2026. GuruFocus rates SENS with a GF Score™ of 60/100 and a GF Value™ of $14.22 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 758 Medical Devices & Instruments companies, Senseonics Holdings ranks worse than 91.03% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Senseonics Holdings's annualized net income for the quarter that ended in Mar. 2026 was $-129.33 Mil. Senseonics Holdings's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $47.25 Mil. Therefore, Senseonics Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was -273.72%.
The historical rank and industry rank for Senseonics Holdings's Return-on-Tangible-Equity or its related term are showing as below:
SENS'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -4945.69 Med: -366.35 Max: -144.9
Current: -144.9
During the past 12 years, Senseonics Holdings's highest Return-on-Tangible-Equity was -144.90%. The lowest was -4,945.69%. And the median was -366.35%.
SENS's Return-on-Tangible-Equity is ranked worse than 91.03% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.08
vs SENS: -144.90
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Senseonics Holdings Return-on-Tangible-Equity Related Terms
Senseonics Holdings Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Senseonics Holdings's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SENS vs LAB, TMCI, SGHT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Senseonics Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senseonics Holdings Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Senseonics Holdings's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -273.72% mean?
Senseonics Holdings (SENS) has a Return-on-Tangible-Equity of -273.72% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Senseonics Holdings and its competitors. According to the industry distribution chart, Senseonics Holdings ranks #690 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 91%.
Is Senseonics Holdings' Return-on-Tangible-Equity too high?
Senseonics Holdings' current Return-on-Tangible-Equity is -273.72%. Based on the distribution chart, Senseonics Holdings ranks #690 out of 758 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Senseonics Holdings has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Senseonics Holdings' Return-on-Tangible-Equity compare to LAB and TMCI?
According to the Medical Devices & Instruments industry distribution chart, Senseonics Holdings ranks #690 out of 758 companies for Return-on-Tangible-Equity. This places Senseonics Holdings in the lower half of its industry. The industry median Return-on-Tangible-Equity is 4.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.08, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Senseonics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senseonics Holdings's current Return-on-Tangible-Equity is -273.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senseonics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Senseonics Holdings (SENS) is currently considered Possible Value Trap. The stock's GF Value™ is $14.22, compared to a current price of $5.33 — trading 62.5% below its estimated fair value. The current Return-on-Tangible-Equity is -273.72%. Senseonics Holdings' overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Senseonics Holdings (SENS), the current Return-on-Tangible-Equity is -273.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Senseonics Holdings (SENS) Overvalued in 2026?
Based on GuruFocus' analysis, Senseonics Holdings stock appears to be undervalued.
The current stock price of $5.33 is trading 62.5% below its estimated GF Value™ of $14.22.
GuruFocus considers Senseonics Holdings to be Possible Value Trap.
Key valuation signals for SENS:
Return-on-Tangible-Equity: -273.72%
GF Value™: $14.22 vs. price of $5.33 (62.5% below fair value)
No single metric tells the full story. See the SENS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
60GF Score
Get the complete analysis for SENS
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SENS has been successfully added to your 
